Bharat Biotech completes paediatric Covaxin trials, to submit data to DCGI by next week Ruchika Sharma22 Sept 2021 12:31 PM ISTHyderabad: Bharat Biotech has completed the Phase 2/3 trials of COVID-19 vaccine, Covaxin for use in children under 18 years of age and is expected to...
Bharat Biotech Covaxin likely to get WHO emergency use nod by October 5 Ruchika Sharma20 Sept 2021 11:18 AM ISTNew Delhi: World Health Organisation's (WHO) approval for the emergency use authorisation (EUA) to COVID-19 vaccine Covaxin, developed by the...
Bharat Biotech awaits WHO feedback for Covaxin emergency use listing Ruchika Sharma18 Sept 2021 12:54 PM ISTNew Delhi: Bharat Biotech on Friday said it has submitted all the data to the World Health Organisation (WHO) for Emergency Use Listing (EUL) of its...
ABB commissions ACS560 drives at Bharat Biotech for safe Covaxin production Ruchika Sharma8 Sept 2021 9:00 AM ISTNew Delhi: ABB India on Tuesday said the company has commissioned its ACS560 drives, which enhance safety and energy efficiency, at Bharat Biotech's...
Bharat Biotech seeks international partners to scale up Covaxin production Ruchika Sharma30 Aug 2021 1:57 PM ISTNew Delhi: Indian vaccine maker Bharat Biotech is seeking international manufacturing partners as it targets a billion doses of its COVID-19 vaccine...
Union Health Minister releases first commercial batch of Covaxin MD Bureau30 Aug 2021 11:00 AM IST"Released the first commercial batch of COVAXIN from Bharat Biotech's plant at Ankleshwar, Gujarat today. This will increase the supply of vaccine in...
COVID: Covaxin single-dose to infected equivalent to 2 doses for unaffected, claims ICMR study MD Bureau29 Aug 2021 10:45 AM ISTNew Delhi: A single-dose of Covaxin provides a similar immunity response in previously Covid-infected people as those without previous history of...
Bharat Biotech, IVI begin Chikungunya vaccine Phase 2, 3 trial in Costa Rica Ruchika Sharma25 Aug 2021 11:00 AM ISTHyderabad: The International Vaccine Institute (IVI) has announced that the first participant received Bharat Biotech's Chikungunya vaccine candidate...
DCGI likely to approve Covaxin for kids prior trial period MD Bureau23 Aug 2021 11:00 AM ISTBengaluru: The Central government and the Drugs Controller General of India (DCGI) may give approval to the Covaxin vaccines for children soon for...
India has done better than other countries in COVID vaccination: Bharat Biotech CMD Ruchika Sharma16 Aug 2021 12:02 PM ISTNew Delhi: India has done better than any country in the world as regards to affordability and the reach to the people of COVID-19 vaccines, Bharat...
CDSCO grants loan license to PSU for supplying Covaxin drug substance to Bharat Biotech Ruchika Sharma15 Aug 2021 11:00 AM ISTNew Delhi: Hyderabad-based PSU Indian Immunologicals Limited has received a loan license from drug regulator CDSCO for supplying to Bharat Biotech...
Over 70 million Covaxin doses supplied, more in pipeline: Bharat Biotech Ruchika Sharma13 Aug 2021 10:00 AM ISTSuchitra Ella said that Covaxin has 65 percent efficacy against Delta variant of Covid-19.
